Assessing the effects of therapeutic combinations on SARS-CoV-2 infected patient outcomes: A big data approach.
Hamidreza MoradiH Timothy BunnellBradley S PriceMaryam KhodaverdiMichael T VestJ Zachary PorterfieldAlfred Jerrod AnzaloneSusan L SantangeloWesley KimbleJeremy HarperWilliam B HillegassSally L Hoddernull nullPublished in: PloS one (2023)
This machine learning model by accurately predicting the mortality provides insights about the treatment combinations associated with clinical improvement in COVID-19 patients. Analysis of the model's components suggests benefit to treatment with combination of steroids, antivirals, and anticoagulant medication. The approach also provides a framework for simultaneously evaluating multiple real-world therapeutic combinations in future research studies.